Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection
- PMID: 19625481
- PMCID: PMC2738110
- DOI: 10.1128/JCM.00609-09
Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection
Abstract
Enzyme immunoassays (EIA) to detect glutamate dehydrogenase or toxins A (TcdA) and B (TcdB), a cytotoxicity assay, and bacteriologic culture have disadvantages when applied individually to diagnosis of Clostridium difficile infections. Stool specimens (n = 1,596) were subjected to toxin detection via an enzyme-linked fluorescent immunoassay (ELFA; Vidas CDAB assay) and bacteriologic culture for toxigenic C. difficile in a three-step algorithm with additional toxigenic culture. Isolates (n = 163) from ELFA-negative stool specimens were examined via ELFA for toxin production. We amplified tcdA and tcdB from C. difficile isolates and tcdB from stool specimens that were ELFA positive or equivocal and culture negative, and we compared the results to those obtained with the three-step algorithm. More than 26% of stool specimens (419/1,596) were culture positive, yielding 248 isolates (59.2%) with both toxin genes (tcdA- and tcdB-positive isolates), 88 isolates (21.0%) with either tcdA or tcdB, and 83 (19.8%) that had no toxin genes (tcdA- and tcdB-negative isolates). Among 49 (culture-negative/ELFA-positive or -equivocal) stool specimens, 53.1% (26/49) represented tcdB-positive isolates. Therefore, the total number of PCR-positive cases was 362, and 27.1% (98/362) of these were detected through toxigenic culture. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 63.3%, 96.7%, 90.5%, and 92.4% (ELFA alone); 92.8%, 93.3%, 80.2%, and 97.8% (culture); and 70.7%, 91.4%, 95.5%, and 100% (three-step algorithm ELFA and bacterial culture with toxigenic culture), respectively, with culture and PCR for tcdA and tcdB as the standards. Thus, sensitivity and specificity were highest using culture and ELFA, respectively, but we recommend the three-step algorithm comprising EIA to detect both toxins and toxigenic culture for C. difficile as a practical method for achieving better PPV and NPV.
Figures
Similar articles
-
Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.Anaerobe. 2009 Dec;15(6):266-9. doi: 10.1016/j.anaerobe.2009.09.008. Epub 2009 Sep 20. Anaerobe. 2009. PMID: 19772927
-
Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.J Clin Microbiol. 2010 Jan;48(1):124-30. doi: 10.1128/JCM.00734-09. Epub 2009 Nov 18. J Clin Microbiol. 2010. PMID: 19923482 Free PMC article.
-
Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.J Clin Microbiol. 2010 Jan;48(1):109-14. doi: 10.1128/JCM.01630-09. Epub 2009 Oct 28. J Clin Microbiol. 2010. PMID: 19864479 Free PMC article.
-
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?J Mol Diagn. 2011 Nov;13(6):573-82. doi: 10.1016/j.jmoldx.2011.06.001. Epub 2011 Aug 18. J Mol Diagn. 2011. PMID: 21854871 Free PMC article. Review.
-
The prognostic value of toxin B and binary toxin in Clostridioides difficile infection.Gut Microbes. 2021 Jan-Dec;13(1):1884516. doi: 10.1080/19490976.2021.1884516. Epub 2021 Mar 4. Gut Microbes. 2021. PMID: 33660568 Free PMC article. Review.
Cited by
-
Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.Ann Lab Med. 2016 Mar;36(2):131-7. doi: 10.3343/alm.2016.36.2.131. Ann Lab Med. 2016. PMID: 26709260 Free PMC article.
-
Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.Arch Microbiol. 2021 May;203(4):1683-1690. doi: 10.1007/s00203-020-02148-8. Epub 2021 Jan 18. Arch Microbiol. 2021. PMID: 33459815
-
Laboratory Diagnostic Methods for Clostridioides difficile Infection: the First Systematic Review and Meta-analysis in Korea.Ann Lab Med. 2021 Mar 1;41(2):171-180. doi: 10.3343/alm.2021.41.2.171. Ann Lab Med. 2021. PMID: 33063678 Free PMC article.
-
Comparison of ChromID agar and Clostridium difficile selective agar for effective isolation of C. difficile from stool specimens.Ann Lab Med. 2014 Jan;34(1):15-9. doi: 10.3343/alm.2014.34.1.15. Epub 2013 Dec 6. Ann Lab Med. 2014. PMID: 24422190 Free PMC article.
-
Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting.Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2325-30. doi: 10.1007/s10096-015-2484-9. Epub 2015 Sep 16. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26377204 Free PMC article.
References
-
- al-Barrak, A., J. M. Embil, B. Dyck, K. Olekson, D. Nicoll, M. Alfa, and A. Kabani. 1999. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can. Commun. Dis. Rep. 2565-69. - PubMed
-
- Aldeen, W. E., M. Bingham, A. Aiderzada, J. Kucera, S. Jense, and K. C. Carroll. 2000. Comparison of the Tox A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. Diagn. Microbiol. Infect. Dis. 36211-213. - PubMed
-
- Alfa, M. J., A. Kabani, D. Lyerly, S. Moncrief, L. M. Neville, A. al-Barrack, G. K. H. Harding, B. Dyck, K. Olekson, and J. M. Embil. 2000. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 382706-2714. - PMC - PubMed
-
- Anderson, M. A., and J. G. Songer. 2008. Evaluation of two enzyme immunoassay for detection of Clostridium difficile toxin A and B in swine. Vet. Microbiol. 128204-206. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical